Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors

There have been few reports of a response to dasatinib or nilotinib after failure of two prior sequential tyrosine kinase inhibitors. We report the outcome of 82 chronic phase patients who received nilotinib or dasatinib as third-line alternative tyrosine kinase inhibitor therapy. Thirty-four patien...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Rossi, Antonella Russo, Breccia, Massimo, Abruzzese, Elisabetta, Castagnetti, Fausto, Luciano, Luigiana, Gozzini, Antonella, Annunziata, Mario, Martino, Bruno, Stagno, Fabio, Cavazzini, Francesco, Tiribelli, Mario, Visani, Giuseppe, Pregno, Patrizia, Musto, Pellegrino, Fava, Carmen, Sgherza, Nicola, Albano, Francesco, Rosti, Gianantonio, Alimena, Giuliana, Specchia, Giorgina
פורמט: Artigo
שפה:Inglês
יצא לאור: Ferrata Storti Foundation 2013
נושאים:
Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3659922/
https://ncbi.nlm.nih.gov/pubmed/22801965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.064337
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים